A personalised mRNA vaccine for melanoma, the deadliest form of skin cancer, is expected to be approved for use in the US, Europe and the UK next year. The vaccine is designed to stimulate immune responses against genetic mutations that are unique to an individual’s cancer. When used alongside standard treatment in a late-stage trial, it substantially cut the risk of cancer recurrence or death within the next two years.
→ “I think approval could be quick, and next year sounds reasonable,” says Alan Melcher at the Institute of Cancer Research in London, who wasn’t involved in the trial…
Source: NewScientist | Health
NewScientist
- What are microchimeric cells doing to our brain?
- Personalised cancer vaccine expected to be approved next year
- Brazil presidential election dogged by alleged bias by Meta AI tools
- Body temperature may drive the higher risk of autoimmune conditions in women
- Emily St. John Mandel: ‘I don’t want to write something relentlessly bleak’
NewScientist | Earth
- Earth entered its ‘bad decades’ after dinosaur-ending asteroid strike
- Earth’s geographic poles wander more than we had thought
- Exploring the world’s northernmost caves – in pictures
- Asteroid strike caused global firestorm that incinerated the dinosaurs
- Negatives saved from Shackleton’s Antarctic trip reveal hidden details
NewScientist | Health
- Personalised cancer vaccine expected to be approved next year
- Body temperature may drive the higher risk of autoimmune conditions in women
- Cholesterol may disrupt the brain’s cleaning system in Alzheimer’s disease
- Newly identified ‘circadian depression’ responds poorly to antidepressants
- Parasite-infected mosquitoes released in Europe for first time
NewScientist | Humans
- Why are Homo sapiens the only human species left?
- Archaeologists are uncovering the meaning of a unique rock art site
- Neanderthal skeleton found with horrific injuries
- Ancient shipwreck discovered off Turkey claimed to be world’s oldest
- The Monte Verde controversy is back: who first lived in the Americas?
